JP2021534183A5 - - Google Patents
Info
- Publication number
- JP2021534183A5 JP2021534183A5 JP2021507907A JP2021507907A JP2021534183A5 JP 2021534183 A5 JP2021534183 A5 JP 2021534183A5 JP 2021507907 A JP2021507907 A JP 2021507907A JP 2021507907 A JP2021507907 A JP 2021507907A JP 2021534183 A5 JP2021534183 A5 JP 2021534183A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- composition according
- composition
- tubulin
- conjugate
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862765099P | 2018-08-16 | 2018-08-16 | |
| US62/765,099 | 2018-08-16 | ||
| PCT/US2019/046944 WO2020037285A1 (en) | 2018-08-16 | 2019-08-16 | Method and composition for stimulating immune response |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534183A JP2021534183A (ja) | 2021-12-09 |
| JPWO2020037285A5 JPWO2020037285A5 (https=) | 2022-08-24 |
| JP2021534183A5 true JP2021534183A5 (https=) | 2022-08-24 |
Family
ID=69525893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507907A Pending JP2021534183A (ja) | 2018-08-16 | 2019-08-16 | 免疫応答を刺激するための方法及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210177952A1 (https=) |
| EP (1) | EP3836930A4 (https=) |
| JP (1) | JP2021534183A (https=) |
| KR (1) | KR20210047309A (https=) |
| CN (1) | CN112638388A (https=) |
| AU (1) | AU2019320830A1 (https=) |
| CA (1) | CA3109223A1 (https=) |
| MX (1) | MX2021001762A (https=) |
| WO (1) | WO2020037285A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX383691B (es) | 2015-03-06 | 2025-03-14 | Beyondspring Pharmaceuticals Inc | Método de tratamiento de cáncer asociado con una mutación de ras. |
| US10155748B2 (en) | 2015-07-13 | 2018-12-18 | Beyondspring Pharmaceuticals, Inc. | Plinabulin compositions |
| LT3400019T (lt) | 2016-01-08 | 2022-12-12 | Ascendis Pharma Growth Disorders A/S | Cnp provaistai su prie žiedo fragmento prijungtu nešikliu |
| IL297375B2 (en) | 2016-01-08 | 2024-02-01 | Ascendis Pharma Growth Disorders As | Controlled-release CNP agonists with low NPR–C binding |
| IL259827B2 (en) | 2016-01-08 | 2025-07-01 | Ascendis Pharma Growth Disorders As | Controlled-release CNP agonists with low initial NPR-B activity |
| NZ743487A (en) | 2016-01-08 | 2023-02-24 | Ascendis Pharma Growth Disorders As | Controlled-release cnp agonists with increased nep stability |
| WO2017118707A1 (en) | 2016-01-08 | 2017-07-13 | Ascendis Pharma Growth Disorders A/S | Controlled-release cnp agonists with reduced side-effects |
| WO2017139231A1 (en) | 2016-02-08 | 2017-08-17 | Beyondspring Pharmaceuticals, Inc. | Compositions containing tucaresol or its analogs |
| RU2760348C2 (ru) | 2016-06-06 | 2021-11-24 | Бейондспринг Фармасьютикалс, Инк. | Способ уменьшения нейтропении |
| HUE062117T2 (hu) | 2016-09-29 | 2023-09-28 | Ascendis Pharma Growth Disorders As | Kombinációs terápia szabályozott felszabadulású CNP agonistákkal |
| JP2020503363A (ja) | 2017-01-06 | 2020-01-30 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | チューブリン結合化合物およびその治療的使用 |
| BR112019015974A2 (pt) | 2017-02-01 | 2020-03-31 | Beyondspring Pharmaceuticals, Inc. | Método para reduzir neutropenia |
| KR20200112881A (ko) | 2018-01-24 | 2020-10-05 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법 |
| CA3215047A1 (en) | 2021-04-09 | 2022-10-13 | Lan Huang | Therapeutic compositions and methods for treating tumors |
| JP2024538730A (ja) * | 2021-10-07 | 2024-10-23 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | がん及び腫瘍を治療するための方法 |
| AU2023219702A1 (en) * | 2022-02-10 | 2024-09-05 | Beyondspring Pharmaceuticals, Inc. | Stable plinabulin formulations and methods of their preparation and use |
| CN117860672A (zh) | 2022-10-11 | 2024-04-12 | 大连万春布林医药有限公司 | 一种普那布林胶束组合物及其制备方法 |
| WO2025151374A1 (en) * | 2024-01-08 | 2025-07-17 | Beyondspring Pharmaceuticals, Inc. | Oncology combination therapy and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040197312A1 (en) * | 2003-04-02 | 2004-10-07 | Marina Moskalenko | Cytokine-expressing cellular vaccine combinations |
| US20100260677A1 (en) * | 2009-03-02 | 2010-10-14 | Massachusetts Institute Of Technology | Methods and systems for treatment and/or diagnosis |
| CN101766815B (zh) * | 2009-12-31 | 2012-04-25 | 胡松华 | 紫杉醇及多西紫杉醇的用途 |
| WO2013124867A1 (en) * | 2012-02-21 | 2013-08-29 | Amrita Vishwa Vidyapeetham University | Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules |
| AU2016219204B2 (en) * | 2015-02-12 | 2021-01-21 | Beyondspring Pharmaceuticals, Inc. | Use of Plinabulin in combination with immune checkpoint inhibitors |
| JP2020503363A (ja) * | 2017-01-06 | 2020-01-30 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | チューブリン結合化合物およびその治療的使用 |
-
2019
- 2019-08-16 CA CA3109223A patent/CA3109223A1/en active Pending
- 2019-08-16 AU AU2019320830A patent/AU2019320830A1/en not_active Abandoned
- 2019-08-16 US US17/268,380 patent/US20210177952A1/en not_active Abandoned
- 2019-08-16 CN CN201980054515.0A patent/CN112638388A/zh active Pending
- 2019-08-16 EP EP19849560.8A patent/EP3836930A4/en not_active Withdrawn
- 2019-08-16 KR KR1020217006506A patent/KR20210047309A/ko not_active Ceased
- 2019-08-16 MX MX2021001762A patent/MX2021001762A/es unknown
- 2019-08-16 JP JP2021507907A patent/JP2021534183A/ja active Pending
- 2019-08-16 WO PCT/US2019/046944 patent/WO2020037285A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534183A5 (https=) | ||
| JPWO2020037285A5 (https=) | ||
| EP1946772B1 (en) | Multivalent vaccine composition | |
| Plotkin et al. | The development of vaccines: how the past led to the future | |
| JP4870895B2 (ja) | ワクチン組成物 | |
| AP567A (en) | Combined vaccines comprising hepatitis B surface antigen and other antigens. | |
| US9669084B2 (en) | Pneumococcal dosing regimen | |
| JP2004501873A5 (https=) | ||
| JP2010502679A (ja) | ワクチン | |
| EP2362781A1 (en) | Combination vaccine with acellular pertussis | |
| RU2013136397A (ru) | Комбинированная семивалентная вакцина | |
| Chavda et al. | History of vaccination | |
| RU2007142383A (ru) | Экспрессирующийся поверхностный антиген вируса гепатита в для получения вакцины | |
| Akarsu et al. | Possible Cutaneous Adverse Effects of AntiInfective Vaccinations | |
| RU2021102185A (ru) | Способ и композиция для стимуляции иммунного ответа | |
| RU2014147491A (ru) | Антигены и антигенные композиции | |
| Hay | What you need to know | |
| Božić et al. | An overview of current vacccines for the prophylaxis of bacterical infections Pres | |
| TW201008577A (en) | Vaccine composition | |
| Axelsen | Immunomodulators and Immunizing Agents | |
| Al-Jadiry | Childhood Immunization | |
| Backx et al. | Immunization | |
| Parnham | opments in vaccinology will be outlined. | |
| Hendriksen | Vaccine development: past, present and future | |
| JPWO2020117618A5 (https=) |